Aspen Pharmacare Holdings Price Prediction
| APNHFDelisted Stock | USD 12.25 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Aspen Pharmacare hype-based prediction, you can estimate the value of Aspen Pharmacare Holdings from the perspective of Aspen Pharmacare response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aspen Pharmacare to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Aspen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aspen Pharmacare after-hype prediction price | USD 12.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aspen |
Aspen Pharmacare After-Hype Price Prediction Density Analysis
As far as predicting the price of Aspen Pharmacare at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aspen Pharmacare or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Aspen Pharmacare, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aspen Pharmacare Estimiated After-Hype Price Volatility
In the context of predicting Aspen Pharmacare's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aspen Pharmacare's historical news coverage. Aspen Pharmacare's after-hype downside and upside margins for the prediction period are 12.25 and 12.25, respectively. We have considered Aspen Pharmacare's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aspen Pharmacare is very steady at this time. Analysis and calculation of next after-hype price of Aspen Pharmacare Holdings is based on 3 months time horizon.
Aspen Pharmacare Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aspen Pharmacare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aspen Pharmacare backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aspen Pharmacare, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
12.25 | 12.25 | 0.00 |
|
Aspen Pharmacare Hype Timeline
Aspen Pharmacare Holdings is presently traded for 12.25. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aspen is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Aspen Pharmacare is about 0.0%, with the expected price after the next announcement by competition of 12.25. About 19.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.98. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aspen Pharmacare Holdings last dividend was issued on the 22nd of September 2022. The entity had 1:3 split on the 19th of April 2016. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.Aspen Pharmacare Related Hype Analysis
Having access to credible news sources related to Aspen Pharmacare's direct competition is more important than ever and may enhance your ability to predict Aspen Pharmacare's future price movements. Getting to know how Aspen Pharmacare's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aspen Pharmacare may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AXRX | Amexdrug | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ANTCF | Aion Therapeutic | 0.00 | 0 per month | 20.40 | 0.16 | 84.21 | (60.00) | 451.80 | |
| ATHJF | Antisense Therapeutics Limited | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 330.62 | |
| ABTI | Alterola Biotech | 0.00 | 0 per month | 0.00 | 0.09 | 32.76 | (2.44) | 171.75 | |
| BCBCF | The BC Bud | 0.00 | 0 per month | 9.19 | 0.16 | 26.81 | (10.61) | 425.33 | |
| CRRTF | Crescita Therapeutics | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 2,097 |
Aspen Pharmacare Additional Predictive Modules
Most predictive techniques to examine Aspen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aspen using various technical indicators. When you analyze Aspen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aspen Pharmacare Predictive Indicators
The successful prediction of Aspen Pharmacare stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aspen Pharmacare Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aspen Pharmacare based on analysis of Aspen Pharmacare hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aspen Pharmacare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aspen Pharmacare's related companies.
Story Coverage note for Aspen Pharmacare
The number of cover stories for Aspen Pharmacare depends on current market conditions and Aspen Pharmacare's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aspen Pharmacare is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aspen Pharmacare's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Aspen Pharmacare Short Properties
Aspen Pharmacare's future price predictability will typically decrease when Aspen Pharmacare's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aspen Pharmacare Holdings often depends not only on the future outlook of the potential Aspen Pharmacare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aspen Pharmacare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 444.9 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Aspen Pink Sheet
If you are still planning to invest in Aspen Pharmacare Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aspen Pharmacare's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |